Erasca Inc (ERAS) concluded trading on Thursday at a closing price of $1.45, with 3.93 million shares of worth about $5.7 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -46.30% during that period and on May 29, 2025 the price saw a gain of about 31.82%. Currently the company’s common shares owned by public are about 283.27M shares, out of which, 160.60M shares are available for trading.
Stock saw a price change of 18.85% in past 5 days and over the past one month there was a price change of 1.40%. Year-to-date (YTD), ERAS shares are showing a performance of -42.23% which decreased to -44.87% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.01 but also hit the highest price of $3.45 during that period. The average intraday trading volume for Erasca Inc shares is 1.64 million. The stock is currently trading 11.07% above its 20-day simple moving average (SMA20), while that difference is up 9.87% for SMA50 and it goes to -32.47% lower than SMA200.
Erasca Inc (NASDAQ: ERAS) currently have 283.27M outstanding shares and institutions hold larger chunk of about 52.64% of that.
The stock has a current market capitalization of $410.77M and its 3Y-monthly beta is at 1.00. It has posted earnings per share of -$0.62 in the same period. It has Quick Ratio of 12.35 while making debt-to-equity ratio of 0.13. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ERAS, volatility over the week remained 16.67% while standing at 8.92% over the month.
Stock’s fiscal year EPS is expected to rise by 30.41% while it is estimated to decrease by -6.81% in next year. EPS is likely to grow at an annualized rate of 11.09% for next 5-years, compared to annual growth of -46.86% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Raymond James on March 26, 2025 offering an Outperform rating for the stock and assigned a target price of $5 to it. Coverage by Jefferies stated Erasca Inc (ERAS) stock as a Buy in their note to investors on November 18, 2024, suggesting a price target of $6 for the stock. On March 11, 2024, CapitalOne Initiated their recommendations, while on January 05, 2024, BofA Securities Downgrade their ratings for the stock with a price target of $6. Stock get a Buy rating from H.C. Wainwright on October 11, 2023.
